Ro Weight Loss Review 2026: How Does Ro Work? Cost, Verdict
Ro Body process and costs. Trimi compounded semaglutide: $99/month equivalent, billed $1,188 upfront for a 12-month annual plan.
Medication charges are separate; confirm the current offer and full amount due before enrolling.
Quick answer
Ro describes an online assessment and provider review for its Body program, with access to GLP-1 medications if prescribed. Video requirements vary by state, and the medication and fulfillment arrangements depend on the approved treatment. Its current weight-loss pages list FDA-approved medications such as Wegovy. Trimi's compounded semaglutide annual plan has an effective monthly price of $99, billed $1,188 upfront for a 12-month commitment. A licensed provider reviews each assessment and decides whether to prescribe. Individual results vary.
More on GLP-1 Provider Comparisons
What Is the Ro Body Program?
Ro was founded in 2017 and now markets the Ro Body weight-management program. Its current program information describes an online assessment, provider review and ongoing support for patients prescribed treatment.
The Ro Body program connects patients with providers who can prescribe GLP-1 medications when appropriate. Patients complete an online health assessment and a provider reviews their information. A prescription and medication access depend on that review. Ro describes shipping through its pharmacy network and also permits patients to choose another pharmacy.
Ro's current weight-loss pages list FDA-approved medications, including Wegovy, Ozempic and Zepbound. Approved indications differ by product, and a provider determines whether a medication is appropriate. Check the selected product, insurance or cash-pay pathway and fulfillment arrangements directly with Ro.
To compare Ro Body with Trimi, review pricing, medication sourcing, provider access and follow-up arrangements for the specific plan.
Ro Body Pricing: What Patients Actually Pay
Ro bills its Body membership separately from medication. The total depends on the selected medication, dose, billing term and insurance or cash-pay pathway. Check Ro's current pricing page and your full payment quote. Our Ro pricing guide provides additional context.
In its March 31, 2026 announcement, Ro described cash-pay access to the Wegovy pen and pill through 3-, 6- and 12-month prepaid options. Ro also describes insurance-coverage and prior-authorization support. Coverage, any manufacturer savings eligibility and the amount due must be confirmed for the selected medication and plan.
For GLP-1 access through Trimi, compare the full plan charge and billing term. The compounded semaglutide annual plan is $99/month equivalent, billed $1,188 upfront for a 12-month commitment. That equivalent is not a monthly installment. A licensed provider reviews each assessment and decides whether to prescribe.
Cost Comparison Context
Confirm the medication, dose, billing term and full amount due directly with each service before enrolling. Trimi's annual-plan equivalent is a division of its upfront charge, not a monthly installment. For more context, see our guide on semaglutide pricing.
Medication Options: Brand-Name vs. Compounded
Ro's current weight-loss pages list FDA-approved medications such as Wegovy. Medication selection depends on the individual provider assessment and the selected product's indications and safety information.
Brand-name products include Ozempic and Wegovy (semaglutide by Novo Nordisk) and Mounjaro and Zepbound (tirzepatide by Eli Lilly). These are FDA-approved products, with different approved indications; Ozempic and Mounjaro are not approved for weight loss. Check the specific product's prescribing information for its formulation, indications and instructions, and confirm the current quote and availability directly with the provider or dispensing pharmacy.
Compounded semaglutide and tirzepatide offered by Trimi are prepared by a 503A pharmacy for an individual prescription. Compounded medications are not FDA-approved; FDA does not review them for safety, effectiveness or quality before marketing. FDA says compounded drugs should only be used when a patient's medical needs cannot be met by an FDA-approved drug. A patient-specific prescription alone does not remove restrictions on drugs that are essentially copies of commercially available drugs. Read the FDA's compounding Q&A and discuss whether treatment is appropriate with a licensed provider.
Trimi identifies BelieveRx (Texas State Board of Pharmacy license #35264) as its 503A community sterile compounding pharmacy. Plan prices depend on the selected billing term and stay the same across prescribed doses within that plan. A pharmacy license does not establish FDA approval of a compounded medication or identify the pharmacy assigned to an individual prescription. Learn more about compounded semaglutide safety considerations and our Ro semaglutide review.
How Does Ro Work for Weight Loss? Step by Step
Ro describes an online health assessment followed by provider review. A video visit may be required depending on the patient's state. If prescribed, medication can be fulfilled through Ro's pharmacy network or another pharmacy the patient chooses. Ro's Body membership describes ongoing provider check-ins and messaging. The main steps are:
- Complete the online health assessment. Provide accurate health information for the reviewing provider.
- A provider reviews your information. Ro says video requirements vary by state.
- The provider evaluates whether treatment is appropriate. Eligibility depends on the selected medication and individual assessment.
- If approved, your prescription is issued. Depending on your pathway, that can mean a brand-name medication such as Wegovy, through insurance or cash pay.
- Confirm pharmacy and delivery arrangements. Ro permits patients to choose its pharmacy network or another pharmacy.
- Confirm ongoing care and billing. Ro describes provider check-ins, messaging and treatment guidance through its Body membership.
Ro's public information describes provider review of the patient's health history and treatment goals. Provide accurate information during the assessment and confirm any additional information or visit the provider requires.
Ro says video requirements depend on the patient's state. A provider decides whether to prescribe after the online visit; the selected medication's indications and safety information matter. Ro's pharmacy network is one fulfillment option, and patients may choose another pharmacy. Confirm medication availability and fulfillment arrangements for the individual prescription.
Check Ro's current information for its assessment process, provider access and follow-up arrangements.
At Trimi, a licensed provider reviews each assessment, may request additional information and decides whether to prescribe. Share your current medications, treatment history and any nausea and GI symptoms with the reviewing provider. Treatment and dose decisions depend on that individual review. For a step-by-step overview of how online GLP-1 prescribing works, see our guide on getting GLP-1 prescribed online.
Medication Side Effects and Safety
Side effects depend on the prescribed medication. In the STEP 1 trial, 44.2% of adults receiving once-weekly 2.4 mg semaglutide injections reported nausea during 68 weeks of treatment with lifestyle intervention. That trial does not establish outcomes for Trimi's compounded preparations. Current Wegovy prescribing information lists nausea, diarrhea, vomiting and constipation among common adverse reactions, and warns about pancreatitis, gallbladder disease and increased hypoglycemia risk with insulin or insulin secretagogues such as sulfonylureas. The timing and severity of side effects vary; discuss symptoms with the prescribing provider.
To assess a service, check the prescribing provider's credentials, state authorization and access to follow-up care. A platform review does not establish that a specific prescription or preparation is safe for an individual patient. Wegovy is contraindicated with a personal or family history of medullary thyroid carcinoma, MEN 2 or a prior serious hypersensitivity reaction to semaglutide or its excipients. A history of pancreatitis and pregnancy require separate discussion with the provider under the selected product's current safety information. For further reading, see our guide to Ro weight loss side effects and our guide to semaglutide side effects.
Pros and Cons of Ro Body for GLP-1 Access
Ro Body: Strengths
Online assessment and provider review, with a video visit when required
Access to FDA-approved medication options if prescribed, with insurance and cash-pay pathways
Provider check-ins and on-demand messaging described in the Body membership
Ability to choose Ro's pharmacy network or another pharmacy
Insurance navigation support for patients seeking coverage for brand-name medications
Ro Body: Limitations
Insurance coverage and prior authorization depend on the medication and individual plan
Confirm who reviews your assessment, how to contact the care team and any required follow-up
Confirm which medications Ro currently offers rather than assuming availability from an older review
Confirm the review and fulfillment estimates for your selected treatment before arranging a switch
Ro Body vs. Trimi: A Direct Comparison
When comparing Ro Body and Trimi for GLP-1 care, review the medication, total charge, billing commitment, provider access and fulfillment arrangements for the specific plan.
Pricing: Trimi offers compounded GLP-1 medications, which are not FDA-approved, at published cash-pay rates. Ro bills its membership separately from medication; check Ro's current pricing page or our Ro pricing guide for context. See also our GLP-1 provider cost guide and our breakdown of the cost landscape for semaglutide.
Provider review: A licensed provider reviews each Trimi assessment and decides whether treatment is appropriate. Confirm each service's provider credentials, follow-up arrangements and contact options before enrolling.
Medication options: Trimi offers compounded semaglutide and tirzepatide. A licensed provider determines whether a treatment is appropriate after reviewing the individual assessment. For the GLP-1 medications Ro currently offers, check Ro's weight-loss pages directly.
Review and fulfillment: A Trimi provider reviews a completed assessment and may request additional information before deciding whether to prescribe. Confirm provider-review, pharmacy-fulfillment and shipping estimates for the selected service. A switching request does not establish a prescription, a delivery deadline or uninterrupted supply.
Insurance and account preferences: Patients considering Ro for brand-name GLP-1 medication should confirm its current insurance-navigation services, coverage requirements and cash-pay options. Patients who already use Ro for other health needs may also consider their account and care preferences.
Our Verdict on Ro for Weight Loss
Compare Ro's current membership, medication and insurance conditions with Trimi's published cash-pay terms. Trimi offers compounded semaglutide and tirzepatide, which are not FDA-approved. Its compounded semaglutide annual plan is $99/month equivalent, billed $1,188 upfront for a 12-month commitment.
Choosing a service depends on the prescribed medication, full payment quote, billing commitment and access to provider support. A licensed provider reviews each Trimi assessment and decides whether to prescribe.
For either service, check the prescribing provider and dispensing pharmacy rather than treating a platform description as credential verification. Follow your provider's dosing guidance and discuss the lifestyle changes and follow-up appropriate to your treatment. For further reading, explore our GLP-1 guide.
Frequently Asked Questions
What is the Ro Body program?
The Ro Body program is Ro's telehealth weight-management service. Ro describes an online health assessment, provider review, access to GLP-1 medications if prescribed, ongoing check-ins, messaging and treatment guidance. Its current weight-loss pages list FDA-approved medications such as Wegovy.
What are the most common Ro weight loss side effects?
Side effects depend on the medication prescribed. For Wegovy (semaglutide), the prescribing information lists nausea, diarrhea, vomiting and constipation among common adverse reactions, and includes warnings about pancreatitis and gallbladder disease. Wegovy is contraindicated with a personal or family history of medullary thyroid carcinoma, MEN 2 or a prior serious hypersensitivity reaction to semaglutide or its excipients. Review the selected medication's current prescribing information and discuss your history and symptoms with the prescribing provider.
How much does Ro Body cost per month?
Ro bills its Body membership separately from medication. The total depends on the medication, dose, billing plan and insurance or cash-pay pathway. Check Ro's current pricing page and your full payment quote before enrolling.
Does Ro prescribe brand-name Ozempic or Wegovy?
Ro's current weight-loss pages list Ozempic and Wegovy. Ozempic is approved for type 2 diabetes and other specified indications, not weight loss; a provider may prescribe it off-label. Wegovy has a weight-management indication. In its March 31, 2026 announcement, Ro described cash-pay access to the Wegovy pen and pill. Confirm the selected medication, prescription eligibility, coverage and availability directly with Ro.
Is Ro a legitimate telehealth company?
Ro is a telehealth company founded in 2017. Its published information describes provider review and access to GLP-1 medications through the Body program if prescribed. Before enrolling, check the prescribing provider's credentials and authorization to practice in your state, and identify the dispensing pharmacy. A company's history does not verify an individual provider or prescription.
Can I switch from Ro to Trimi?
To request a switch, complete Trimi's online health assessment and provide your current medication, dose and treatment history. A licensed provider reviews that information, may request additional information and decides whether to prescribe and which treatment plan is appropriate. Do not assume approval, continuation at the same dose or an uninterrupted medication supply.
Does Ro offer tirzepatide?
Ro's current weight-loss pages list Zepbound, a tirzepatide product, subject to provider review and prescription eligibility. Confirm current medication options and billing directly with Ro. Trimi offers compounded semaglutide and tirzepatide, which are not FDA-approved. A licensed provider reviews each Trimi assessment and decides whether treatment is appropriate.
What is the difference between Ro Body and Trimi for weight loss?
Compare the medication, full amount due, billing term and access to provider support. Ro Body is part of Ro's broader telehealth platform; confirm its current medication options and insurance or cash-pay conditions directly. Trimi offers compounded semaglutide and tirzepatide, which are not FDA-approved. A licensed provider reviews each Trimi assessment and decides whether to prescribe.
Sources & References
- Ro. Official Body program and pricing information, checked October 2026.
- STEP 1 trial: semaglutide in adults with overweight or obesity (PubMed).
- SURMOUNT-1 trial: tirzepatide for obesity (PubMed).
- FDA guidance on compounding and the FDA.
- Historical Wegovy FDA prescribing information, 2023. Check the current product label for current safety information.
- Historical Zepbound FDA prescribing information, 2023. Check the current product label for current safety information.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Confirm current pricing and availability directly with each service. Trimi publishes this comparison and offers a competing service. Treatment selection, eligibility and dosing require individual provider review.